Thanks Allan--I originally had some money in
the Fidelity Select Biotech fund, it has done
very well, but Fidelity tends to move their
fund managers around a lot. The latest manager,
is Rajiv Kaul, and he may be the best they've
got so far. I move my select sector money
around each year, just to capture 25%--once I've
got it, I'm back in cash--if I can do that for
twenty years a McFarland can go to Stanford,
if she wants to go there <g>.
I started my Roth IRA last year, went for the
Franklin Biotechnology Discovery Fund--it'll
be awhile before I've much in that one. The
Fidelity and the Franklin fund share several
of the goliaths, Amgen etc, and also one stock
I was beginning to look at--Gilead, GILD, but
it keeps trending down--maybe these fellas are
selling it, needless to say, I'll wait til it
bottoms out.
Two others funds are Janus Global Life fund--JAGLX,
and the Murphy biotech fund--MNWBX. So far I seem
to be beating the performance of those two, on
any given day this past month I'm up 60-85% for
the year, so I'm not rushing out to get into those
two.
I agree that handpicking individual stocks ain't
easy, but hopefully more rewarding. And I'd have
done better if I hadn't doubled down--twice--in
one idea, and then finally got stopped out. Take
that foolishness out of the equation and I'd be
beating all the funds. So I'll keep plugging away
at this for now.
I think if a person ran a portfolio off the biogurus
ideas, and then restricted them to just a trade a week,
I'll bet they'd best just about anybody--but nobody
is going to hire half a dozen fellows just to manage
one fund. The trick I'd say is to get everybody on the
same team--for instance, imagine if that fella from
Fidelity worked with the BancBoston biotech research
team--and they got a trade a week from the SI bioguys,
I'd buy that fund and quit doing my own picks pretty
quick, but that sort of effort just isn't available
for you and me, they'd be charging a ten percent load
just to keep the riff raff out;-) |
